Cryo-Cell International, Inc. (CCEL) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 32.11M |
| Enterprise Value | 43.35M |
| P/E Ratio | -11.07 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0.92 |
| Price/Book Ratio | -1.57 |
| Enterprise/Revenue | 0.99 |
| Enterprise/EBITDA | 52.69 |
| Fiscal Year | November 30, 2025 |
| Most Recent Quarter | February 28, 2026 |
| Profit Margin | -0.09 |
| Operating Margin | 0.01 |
| Return On Assets | -0.04 |
| Return On Equity | 0.16 |
| Revenue | 31.57M |
| Revenue/Share | 3.88 |
| Gross Profit | 24.19M |
| EBITDA | 1.1M |
| Net Income | -2.43M |
| Diluted EPS | -0.3 |
| Total Cash | 2.9M |
| Total Cash/Share | 0.36 |
| Total Debt | 2.4M |
| Total Debt/Equity | -0.13 |
| Current Ratio | 0.62 |
| Book Value Per Share | -2.28 |
| 52-Week Change | -24.42 |
| 52-Week High | 5.43 |
| 52-Week Low | 2.72 |
| Moving Average 50 Days | 3.52 |
| Moving Average 200 Days | 3.71 |
| Average Volume | 9,460 |
| Shares Outstanding | 8.06M |
| % Held by Institutions | 6.6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.45 |
| Last Split Factor | N/A |
| Last Split Date | N/A |